Search by Title Article Topic - Any -AdvocacyAnnual Scientific MeetingAwardsBoard Certification ReviewCertificationClinical DocumentClinical TrialsCoronavirusEarly CareerFellowshipFuture LeadersHeart Failure Awareness 365Heart Failure GuidelinesHFSA CommitteesHFSA Comprehensive Heart Failure ReviewHFSA Learning CenterIn The NewsIndustryJournal of Cardiac FailureLeadershipMembershipMentorshipNursingPartnersPatient ResourcePatient StoryPodcastsPresident's UpdatesPress ReleaseProfessional DevelopmentProvider EducationResearchSocial MediaStatementSubmissionsWomen in Heart Failure Article Type - Any -HFSA NewsIndustry NewsPatient NewsPractice News Jun 5 2023 | INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure Industry News In The News Industry Read More Jun 5 2023 | Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care Industry News In The News Industry Read More Jun 1 2023 | Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure Industry News In The News Industry Read More May 25 2023 | Cytokinetics Presents New Data in Patients With Non-Obstructive HCM From Cohort 4 of REDWOOD-HCM in Late-Breaking Clinical Trial Session at The European Society of Cardiology Heart Failure 2023 Congress Industry News In The News Industry Read More May 18 2023 | New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes Industry News In The News Industry Read More Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Jun 5 2023 | INJECTAFER® Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure Industry News In The News Industry Read More
Jun 5 2023 | Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care Industry News In The News Industry Read More
Jun 1 2023 | Lexicon Announces FDA Approval of INPEFA™ (sotagliflozin) for Treatment of Heart Failure Industry News In The News Industry Read More
May 25 2023 | Cytokinetics Presents New Data in Patients With Non-Obstructive HCM From Cohort 4 of REDWOOD-HCM in Late-Breaking Clinical Trial Session at The European Society of Cardiology Heart Failure 2023 Congress Industry News In The News Industry Read More
May 18 2023 | New Study Demonstrates Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in Heart Failure Outcomes Industry News In The News Industry Read More
